Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Can U buy Bucillamine on line ? SOLD OUT !!
View:
Post by cool888 on Sep 15, 2021 8:28pm

Can U buy Bucillamine on line ? SOLD OUT !!

Thanks Sylvain - Yahoo post (again !)

You can buy it on internet for 49.99$ US for 100 tablets of 100mg, but it seem to be sold out. I guess the demand is already rocketting.

https://www.mimaki-family-japan.com/item/detail?item_prefix=TF&item_code=007343&item_branch=002
Comment by cool888 on Sep 15, 2021 8:33pm
Am not sure if this one is REPOURSED for Covid 19 ? !
Comment by MyAli4s on Sep 15, 2021 9:51pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities